|
|
|
|
Vol. 13, Issue 4, 1227-1237, April 2002

*Department of Anatomy and Cell Biology, East Carolina University School of Medicine, Greenville, North Carolina 27858; and §Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115
Submitted August 27, 2001; Revised January 4, 2002; Accepted January 9, 2002| |
ABSTRACT |
|---|
|
|
|---|
Occludin is an integral membrane protein that is tyrosine phosphorylated when localized at tight junctions. When Ca2+ was depleted from the culture medium, occludin tyrosine phosphorylation was diminished from Madin-Darby canine kidney epithelial cells in 2 min. This dephosphorylation was correlated with a significant reduction in transepithelial electrical resistance (TER), indicating a global loss of the tight junction barrier function. Reconstitution of Ca2+ resulted in a robust tyrosine rephosphorylation of occludin that was temporally associated with an increase in TER. Moreover, we demonstrate in this study that occludin was colocalized with the nonreceptor tyrosine kinase c-Yes at cell junction areas and formed an immunoprecipitable complex with c-Yes in vivo. This complex dissociated when the cells were incubated in medium without Ca2+ or treated with a c-Yes inhibitor, CGP77675. In the presence of CGP77675 after Ca2+ repletion, occludin tyrosine phosphorylation was completely abolished and both tight junction formation and the increase of the TER were inhibited. Our study thus provides strong evidence that occludin tyrosine phosphorylation is tightly linked to tight junction formation in epithelial cells, and that the nonreceptor tyrosine kinase c-Yes is involved in the regulation of this process.
| |
INTRODUCTION |
|---|
|
|
|---|
A number of tight junction integral membrane proteins and tight
junction-associated proteins have been identified in the last decade:
occludin, the claudin family, junctional adhesion molecule, zonula occludens (ZO)-1, ZO-2, ZO-3, cingulin, symplekin, and AF6
(reviewed in Stevenson and Keon, 1998
; Goodenough, 1999
; Tsukita et al., 1999
). Among these, occludin is an integral membrane
protein localized within the freeze fracture fibrils that has been
shown to be required for normal tight junction physiology (Furuse
et al., 1993
; Fujimoto, 1995
; Balda et al., 1996
;
McCarthy et al., 1996
; Chen et al., 1997
; Wong
and Gumbiner, 1997
). Occludin has a predicted tetraspanning membrane
topology with two extracellular loops and three cytoplasmic domains
(Furuse et al., 1993
; Ando-Akatsuka et al.,
1996
). It has been shown that the extracellular loops are important for
occludin localization in culture (Wong and Gumbiner, 1997
; Lacaz-Vieira
et al., 1999
; Medina et al., 2000
). The C
terminus of occludin directly interacts with ZO-1 in vitro and is
required for tight junction function (Furuse et al., 1994
;
Balda et al., 1996
; Chen et al., 1997
; Matter and
Balda, 1998
; Mitic et al., 1999
).
Occludin migrates as a tight cluster of multiple bands on SDS gels
resulting from multiple phosphorylation of serine and threonine residues (Sakakibara et al., 1997
; Wong, 1997
; Cordenonsi
et al., 1999
; Farshori and Kachar, 1999
). It has been
suggested that the phosphorylation of occludin is important for tight
junction assembly because highly phosphorylated occludin is selectively
concentrated at tight junctions in a detergent-insoluble form
(Sakakibara et al., 1997
). However, in epithelia of
Xenopus embryos, occludin dephosphorylation was correlated
with the de novo assembly of tight junctions (Cordenonsi et
al., 1999
), suggesting that occludin phosphorylation may play
different roles in different biological systems, or that
phosphorylation of specific residues has different functional consequences.
Studies of tyrosine phosphorylation have revealed contradictory data on
tight junction physiology. Inhibition of phosphatase activity has been
reported to result in decreases in transepithelial electrical
resistance (TER) and increases in paracellular permeability (Staddon
et al., 1995
; Collares-Buzato et al., 1998
;
Atkinson and Rao, 2001
). However, other studies have shown that
tyrosine phosphorylation can be positively temporally correlated with
tight junction assembly and function (Kurihara et al., 1995
;
Tsukamoto and Nigam, 1999
). Tsukamoto and Nigam (1999)
provided the
first evidence that occludin was tyrosine phosphorylated and that
tyrosine kinase activity is necessary for tight junction reassembly
during ATP repletion.
The signaling pathways and kinases involved in occludin phosphorylation
and tight junction function remain unclear. Overexpression of protein
kinase C (PKC)-
(Mullin et al., 1998
) or phorbol ester activation of PKC (Clarke et al., 2000
) leads to the
dephosphorylation of occludin and increased tight junction permeability
in LLC-PK1 renal epithelial cells. It has been shown that epidermal
growth factor induces tyrosine phosphorylation and reorganization of ZO-1 in A431 human epidermal carcinoma cells (Van Itallie et
al., 1995
). Small GTPases, such as Rho and Rac, are also involved
in regulating tight junction structure and function (Nusrat et
al., 1995
; Gopalakrishnan et al., 1998
; Jou et
al., 1998
). Other signaling molecules reported to influence the
function of the tight junction include G proteins, phospholipase C,
Raf-1, calmodulin, and glucocorticoids (Balda et al., 1991
;
Singer et al., 1994
; Denker et al., 1996
; Saha
et al., 1998
; Li and Mrsny, 2000
).
Our previous work demonstrated that in ras-transformed
Madin-Darby canine kidney (MDCK) cells tight junction structure is absent, and occludin, claudin-1, and ZO-1 are present only in the
cytoplasm (Chen et al., 2000
). Under these conditions,
occludin is not tyrosine phosphorylated. When Ras signaling is
attenuated by the inhibition of the mitogen-activated protein
kinase pathway, tight junctions are restored. Occludin, claudin-1, and
ZO-1 are concomitantly recruited to the cell-cell contact areas and
occludin becomes tyrosine phosphorylated. In the present study, we have used normal MDCK II cells to investigate whether occludin tyrosine phosphorylation is required for tight junction formation in epithelial cells. Using a calcium-switch model, we found that occludin tyrosine phosphorylation and dephosphorylation were temporally highly correlated with tight junction assembly and disassembly. Furthermore, we demonstrate that occludin was colocalized and formed an
immunoprecipitable complex with the nonreceptor tyrosine kinase c-Yes
in vivo. Treatment of MDCK cells with a c-Yes inhibitor,
CGP77675, disrupted the occludin/c-Yes complex and completely
abolished the tyrosine phosphorylation of occludin. Our study provides
strong evidence that occludin tyrosine phosphorylation is required for
tight junction formation in epithelial cells, and that the nonreceptor
tyrosine kinase c-Yes is involved in the regulation of tight junction
formation and function.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Antibodies and Reagents
The rabbit polyclonal anti-occludin, anti-claudin-1, and anti-ZO-1 antibodies were purchased from Zymed Laboratories (South San Francisco, CA). The mouse anti-phosphotyrosine and mouse anti-c-Yes monoclonal antibodies (mAbs) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and Transduction Laboratories (Lexington, KY), respectively. Genistein, a broad-range tyrosine kinase inhibitor that inhibits epidermal growth factor receptor tyrosine kinase and p60v-src kinase, was obtained from Calbiochem (San Diego, CA). The c-Yes inhibitor CGP77675 was kindly provided by Dr. Mira Susa (Novartis Pharma AG, Basel, Switzerland). Fluorescein isothiocyanate-conjugated goat anti-rabbit IgG was purchased from Roche Applied Sciences (Indianapolis, IN). Rhodamine-conjugated goat anti-mouse IgG was obtained from Cappel (Malvern, PA).
Cell Culture and Calcium-Switch Assay
MDCK II cells were grown in DMEM containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin in a humidified air, 5% CO2 atmosphere at 37°C. During the calcium-switch experiments, the monolayers were washed three times with Ca2+/Mg2+-free phosphate-buffered saline (PBS) and incubated in Ca2+-free DMEM, 10% dialyzed fetal bovine serum for 1 h or overnight depending on the experiments, and then switched to normal culture medium. At the time of switching back to normal medium the cells were either not treated (control), or treated with 50 µM genistein, or with 200 nM CGP77675 for various lengths of time before fixing for immunohistochemistry or lysed for immunoprecipitation.
Immunofluorescence and Confocal Microscopy
Cells grown on glass coverslips were fixed with 100% methanol
at
20°C for 5 min. Cells were blocked with 2% bovine serum albumin
(BSA) for 30 min at room temperature and incubated with primary
antibodies against occludin (1:300 dilution), claudin-1 (1:100), ZO-1
(1:500), and c-Yes (1:500) for 1 h. All antibodies were diluted in
2% BSA in PBS. After washing, cells were incubated with secondary
antibody for 50 min at room temperature. The secondary antibody used
for occludin, claudin-1, and ZO-1 was fluorescein isothiocyanate-conjugated anti-rabbit IgG (1:400). The rhodamine- (for double labeling) conjugated anti-mouse IgG was used for c-Yes (1:400). Coverslips were mounted with ProLong antifade kit (Molecular Probes, Eugene, OR). Samples were analyzed and photographed using either a Zeiss Axiophot or Zeiss Axiovert S100 (Carl Zeiss, Thornwood, NY). The z-axial images were collected using a Zeiss LSM 510 laser confocal scanning microscopy (Carl Zeiss).
Immunoprecipitation and Western Blot Analysis
MDCK II cells without treatment, with 50 µM genistein, or with 200 nM CGP77675 were washed three times in PBS, and then lysed in radioimmunoprecipitation assay (RIPA) buffer (1% Triton X-100; 0.5% sodium deoxycholate; 0.2% SDS; 150 mM NaCl; 10 mM HEPES, pH 7.3; 2 mM EDTA; 10 µg/ml each of chymostatin, leupeptin, and pepstatin A; 20 µM phenylmethylsulfonyl fluoride; 2 mM sodium orthovanadate; 10 mM sodium pyrophosphate; and 20 mM sodium fluoride). After 20-min incubation at 4°C, the lysates were homogenized on ice by passing 20 times through a 22-gauge needle, and centrifuged at 15,000 × g for 30 min at 4°C. The total protein concentration of each sample was measured by bicinchoninic acid protein assay kit (Pierce Chemical, Rockford, IL) and adjusted to equal concentration (1 mg/ml). After preclearing with protein A- or protein G-Sepharose beads the supernatants were incubated with polyclonal anti-occludin or anti-ZO-1 or monoclonal anti-c-Yes antibody at 4°C overnight. The supernatants were incubated with either protein A-Sepharose (for occludin and ZO-1) or protein G (for c-Yes) for additional 2 h. The beads were washed three times with RIPA buffer, one time with high salt (0.5 M NaCl), and one time with Tris buffer (10 mM Tris, pH 7.4). Bound protein was eluted from the beads in SDS sample buffer and boiled for 5 min.
Cell lysates or immunoprecipitates in SDS sample buffer were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membrane was then blocked in 5% nonfat dried milk or 5% BSA (for anti-phosphotyrosine detection) in Tris-buffered saline plus 0.1% Tween 20, and incubated with primary antibodies for 1.5 h followed by incubation with appropriate secondary antibodies for 1 h. The dilutions for the primary antibodies were as follows: anti-occludin, 1:1000; anti-claudin-1, 1:500; anti-ZO-1, 1:2000; and anti-phosphotyrosine, 1:300. After blotting, the signals were detected by enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ) on X-OMAT film. When necessary, blots were stripped (100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl, pH 7.6) for 30 min at 55°C. The blots were then washed in Tris-buffered saline containing 0.1% Tween 20 before reprobing with specific antibodies.
Measurement of TER
For TER measurements, cells were plated on Transwell filters
with a pore size of 0.4 µm (Corning Glassworks, Cambridge, MA). A
Millicell-ERS volt-ohm meter (Millipore, Bedford, MA) was used to
determine the TER value (McCarthy et al., 1996
). A pair of Ag/AgCl electrodes was placed into the transwell (one electrode was
inserted into up-chamber and the other electrode was inserted into
low-chamber) and an AC square wave current from the volt-ohm meter was
passing across the cell monolayer to obtain the TER values. All the TER
values were determined after the background subtraction (contributed by
filter and bath solution) and multiplied by the surface area of the filter.
| |
RESULTS |
|---|
|
|
|---|
Tyrosine Phosphorylation of Occludin Was Diminished in Ca2+-free Medium
Occludin was tyrosine phosphorylated in confluent MDCK II cells
when cultured in Ca2+-containing medium as shown
in Figure 1A, lane 0. However, after switching to the medium without Ca2+, occludin
tyrosine phosphorylation was diminished within 2 min (Figure 1A, lane
2). In contrast, ZO-1 tyrosine phosphorylation was unchanged until 60 min after Ca2+ depletion (Figure 1B). Occludin
remained tyrosine dephosphorylated for as long as the cells remained in
the Ca2+-free medium (Figure 1A, lanes 10, 30, and 60). An initial sharp drop in TER was closely correlated with the
time of occludin tyrosine dephosphorylation (Figure
2). Each TER measurement was normalized to the initial value (the TER before switching to the
Ca2+-free medium, indicated as 100% in Figure
2). TER continuously decreased over the next hour until reaching its
minimum. Immunohistochemistry showed that the tight junction proteins
occludin, claudin-1, and ZO-1 were all still localized at the cell-cell
contact area after 2 min of Ca2+ depletion,
although the TER had dropped ~40% at this time point (Figure
3, A-C). After 10 min of
Ca2+ depletion, cells detached from each other
and the cell junctions were disrupted (Figure 3, D-F). The
fluorescence intensities of occludin, claudin-1, and ZO-1 on the cell
membrane were reduced and the staining pattern became discontinuous. On
the other hand, the cytoplasmic staining of occludin, claudin-1, and
ZO-1 increased. By 30 min of Ca2+ depletion,
cells were all dissociated from each other, and the fluorescence
staining patterns associated with each of the tight junction proteins
appeared punctate (Figure 3, G and H), or dispersed in the cytoplasm
(Figure 3I). The inserts provided in Figure 3, G-I, are enlarged
images from the same field.
|
|
|
Tyrosine Phosphorylation of Occludin Was Associated with Tight Junction Formation during Ca2+ Repletion
To correlate occludin tyrosine rephosphorylation with tight
junction assembly, cells were switched back to
Ca2+-containing culture medium after 1 h of
Ca2+ depletion. Tyrosine phosphorylation of
occludin appeared clearly at the 1-h time point after
Ca2+ repletion and reached its maximum at 2 and
4 h (Figure 4A). The more slowly
migrating band seen at the 0-, 0.5-, and 1-h time points was not
occludin related because it could not be stained when this membrane was
stripped and reprobed with anti-occludin antibody (our unpublished
data). The total amount of occludin at each time point in Figure 4A was
similar as determined by densitometry of anti-occludin
immunoblots (our unpublished data). The changes in ZO-1
tyrosine phosphorylation during Ca2+ repletion
were much less significant and not correlated with the tight junction
assembly (Figure 4B). The band below ZO-1 was most likely ZO-2 because
these molecules have been shown to coimmunoprecipitate with ZO-1 under
similar experimental conditions (Gumbiner et al., 1991
;
Jesaitis and Goodenough, 1994
). Figure 4C documents that occludin
tyrosine phosphorylation reached a maximum at 2 and 4 h and then
declined to a steady-state level at 8 h. The level of ZO-1
tyrosine phosphorylation did not show a detectable change over the time
course of these experiments (Figure 4D).
|
TER measurements revealed a close temporal correlation between occludin
tyrosine phosphorylation and tight junction formation during
Ca2+ repletion (Figure
5). Cells were incubated in the
Ca2+-free medium for 1 h and then switched
to Ca2+-containing culture medium. As presented
previously (Figure 2), each TER measurement was normalized to the
initial TER value (as 100%) before Ca2+
depletion. As shown in Figure 5, TER overshot its initial value at 2 and 4 h, at which time occludin tyrosine phosphorylation was also
at a maximum (Figure 4, A and C). TER then declined to its initial
value by 8 h (Figure 5) at which time the occludin tyrosine
phosphorylation had also returned to its steady-state level (Figure 4,
A and C).
|
Immunohistochemistry was consistent with the TER measurements. There
was no cell membrane staining with the three tight junction markers
after 1 h of Ca2+ depletion when the cells
were rounded up (Figure 6, A-C). After 0.5 h of Ca2+ repletion, occludin,
claudin-1, and ZO-1 started to appear at some of the cell-cell contact
areas (Figure 6, D-F). The junctional staining of occludin, claudin-1,
and ZO-1 was more obvious at the 1-h time point as shown in Figure 6,
G-I. After the cells were switched back to
Ca2+-containing culture medium for 2 h, the
tight junction was fully assembled as indicated both by
immunofluorescent staining (Figure 6, J-L) and TER measurement (Figure
5).
|
Molecular Interaction of Occludin with Nonreceptor Tyrosine Kinase c-Yes
Immunohistochemistry and immunoprecipitation were used to identify
an upstream tyrosine kinase of occludin. Nusrat et al. (2000)
demonstrated previously that a 27 amino-acid peptide of the
human occludin sequence interacts in vitro with occludin itself, ZO-1,
PKC-
, c-Yes, the regulatory subunit of phosphatidylinositol 3-kinase, and the gap junction component connexin26. Pursuing these
findings, we found that nonreceptor tyrosine kinase c-Yes was
colocalized with occludin at tight junctions and along basolateral membranes in MDCK cells as demonstrated in Figure
7, A-C. Confocal microscopy confirmed
z-axis colocalization of occludin and c-Yes to within
confidence levels of the light microscope (Figure 7, D-F). To
determine whether occludin and c-Yes form a stable complex in vivo,
coimmunoprecipitation experiments were performed. Figure 7G shows that
when MDCK II cell lysates were immunoprecipitated with anti-occludin
antibody, c-Yes was present in the complex as revealed by
immunoblot with an anti-c-Yes antibody. Reciprocal immunoprecipitation with anti-c-Yes antibody followed by
immunoblot with anti-occludin confirmed the interaction of
these two proteins in vivo (Figure 7H). This complex was disrupted in
Ca2+-free medium (see below). We were unable to
detect claudin-1 in this complex as indicated in Figure 7I, although
claudin-1 was robustly present in the cell lysates (Figure 7J). Both
Src and phosphatidylinositol 3-kinases were also undetectable
in this complex (our unpublished data).
|
Inhibition of c-Yes Results in Dissociation of Occludin/c-Yes Complex and Disruption of Tight Junction Formation
MDCK II cells were recovered from low Ca2+
condition in the presence of the tyrosine kinase inhibitors genistein
and CGP77675 to demonstrate a temporal correlation between the presence
of an occludin/c-Yes complex and tight junction reassembly. To
completely dissociate cells from each other and reduce overall
background the overnight Ca2+ depletion condition
was used in tyrosine kinase inhibitor experiments. Cells were
grown overnight in Ca2+-free medium, and then
changed to Ca2+-containing medium without (Figure
8A, lane C), or with the addition of 50 µM genistein (Figure 8A, lane Geni), or 200 nM CGP77675 (Figure 8A,
lane CGP). After 2.5 h, cells were lysed and immunoprecipitated with anti-occludin antibody. All the immunoprecipitates were then probed with anti-phosphotyrosine antibody. Figure 8A shows that genistein treatment only slightly reduced the amount of occludin that
was tyrosine phosphorylated after repletion of
Ca2+. In contrast, CGP77675 treatment completely
abolished the tyrosine phosphorylation of occludin under the identical
conditions. Indirect immunofluorescence light microscopy data revealed
that CGP77675 treatment interfered with tight junction assembly and
denied monolayer formation after switching to
Ca2+-containing medium for 2.5 h (Figure 8B,
CGP). In contrast, the control cells or the cells treated with
genistein formed confluent monolayers with the characteristic
honeycomb-like staining of occludin and ZO-1 (Figure 8B, C and Geni).
|
TER measurements also demonstrated the impairment of tight
junction formation after the cells were treated with c-Yes inhibitor compared with the control cells and genistein-treated cells (Figure 9). After the cells were switched to
Ca2+-containing medium for 3 h, the TER
measured from the control cells and the genistein-treated cells reached
~175% of the initial TER value, whereas the TER from
CGP77675-treated cells had only 50% of the initial TER value. The
effect of CGP77675 was time limited because TER values from all three
conditions were similar by 8 h (our unpublished data).
|
We examined the interaction of occludin with c-Yes tyrosine
kinase in Ca2+-free medium and CGP77675-treated
conditions. Figure 10A shows that c-Yes
and occludin were not associated with each other in Ca2+-free medium. In addition, when cells were
treated with CGP77675 for 2.5 h after switching to
Ca2+-containing medium, the interaction of
occludin and c-Yes was greatly reduced compared with the control cells.
Figure 10B demonstrates that equivalent amounts of c-Yes were
immunoprecipitated under all three conditions. These data were
consistent with those shown in Figures 8A and 9 in which occludin
tyrosine phosphorylation was undetectable after CGP77675 treatment
(Figure 8A) and the TER value in the presence of CGP77675 was much
lower compared with the control and genistein-treated conditions
(Figure 9).
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study we found that occludin tyrosine
phosphorylation tightly correlated with the tight junction formation in
a kidney epithelial cell line. During Ca2+
depletion, the initial quick drop of TER was accompanied by a parallel
tyrosine dephosphorylation of occludin. The occurrence of occludin
tyrosine rephosphorylation after Ca2+ repletion
was closely associated with an increase in TER. These changes in
tyrosine phosphorylation of occludin are significantly more rapid than
occludin turnover (Chen et al., 2000
), indicating recycling
of the occludin molecules at the tight junction rather than degradation
followed by de novo synthesis. The intensity of occludin tyrosine
phosphorylation correlated with the TER value, because both showed a
parallel overshoot 2-4 h after Ca2+ repletion.
In addition, we demonstrated for the first time that the nonreceptor
tyrosine kinase c-Yes was colocalized with occludin at the tight
junction and along basolateral membranes and that occludin and c-Yes
formed a complex in vivo by reciprocal coimmunoprecipitation assay.
These data do not reveal, however, that occludin is the direct
substrate for c-Yes tyrosine kinase activity or that the tyrosine
phosphorylation of occludin is a necessary or sufficient condition for
tight junction assembly. Because tight junctions are known to form in
mice depleted of occludin (Saitou et al., 2000
), more
specific assays of occludin function in the tight junction are required
to dissect the functional meaning of occludin tyrosine phosphorylation.
When the cells were treated with the c-Yes inhibitor CGP77675 after
Ca2+ repletion, tight junction formation and the
establishment of the TER were inhibited or significantly delayed.
CGP77675 also disrupted the occludin/c-Yes complex, and completely
abolished the tyrosine rephosphorylation of occludin. Because CGP77675
inhibits both c-Src and c-Yes (Missbach et al., 1999
; Susa
et al., 2000
), we performed our CGP77675 inhibition assays
in parallel with genistein, an inhibitor of both the epidermal growth
factor receptor kinase and p60v-src kinase
(Akiyama et al., 1987
; Nakanishi et al., 1993
;
Laniyonu et al., 1995
) and herbimycin A, a c-Src tyrosine
kinase inhibitor (Yoneda et al., 1993
; Kuo et
al., 1997
). We found that CGP77675, but not genistein or
herbimycin A (our unpublished data), was able to inhibit both occludin
tyrosine phosphorylation and tight junction reassembly, indicating that
only the inhibition of c-Yes by CGP77675 was relevant. Moreover, we
were unable to immunoprecipitate c-Src kinase with occludin antibodies
(our unpublished data).
Results from the literature also deny Src kinase a role in cell
junction assembly. Overexpression of v-Src in MDCK epithelial cells
rapidly disrupts cell-to-cell contacts and the cells acquire a
fibroblast-like morphology (Behrens et al., 1993
). In Caco-2 cells, expression of v-Src induces
-catenin and
p120ctn tyrosine phosphorylation, redistribution
of E-cadherin to the cytosol, and disassembly of adherens junctions
(Gomez et al., 1999
). These studies indicate that Src kinase
disrupts rather than promotes the assembly of cell-cell junctions.
Finally, two groups have reported that Triton-insoluble membrane
complexes isolated from MDCK cells contain only one major
tyrosine-phosphorylated protein, p62c-yes
(Sargiacomo et al., 1993
; Arreaza et al., 1994
).
The closely related tyrosine kinase p60c-src is
undetectable in these insoluble complexes even when this kinase is
overexpressed in MDCK cells. Taken together, we believe that it is
c-Yes kinase that is involved in occludin tyrosine phosphorylation and
tight junction reassembly.
The effect of CGP77675 had a time window. By 8 h the cells treated
with CGP77675 had a TER value similar to that of the control cells,
indicating that the effect of CGP77675 was specific and not due to
toxicity. The transient inhibitory activity of CGP77675 may have been
due to other nonreceptor tyrosine kinases compensating for the loss of
c-Yes kinase function, as has been postulated (Stein et al.,
1994
; Luton and Mostov, 1999
).
c-Yes is a member of the Src family of tyrosine kinases and was
initially identified as a homolog of v-yes, the oncogene of avian sarcoma virus Y73 (Ghysdael et al., 1981
; Kitamura
et al., 1982
; Sukegawa et al., 1987
). The
c-yes gene is widely expressed in a variety of tissues,
including epithelia such as kidney, liver, lung, and intestine
(reviewed in Brickell, 1992
; Thomas and Brugge, 1997
). In the kidney,
p62c-yes is found in the epithelial cells of the
proximal tubules, which are engaged in transport and secretion
(Sukegawa et al., 1990
). c-Yes is tightly associated with
the membrane and active as a nonreceptor protein tyrosine kinase (Sudol
and Hanafusa, 1986
; Sudol et al., 1988
). Although there are
studies of gene structure and expression patterns, the function of
c-Yes at the cellular level has not been elucidated. Recently, it has
been reported that c-Yes kinase interacts with Yes-associated protein
65 at the apical compartment of airway epithelia by association with ezrin-radixin-moesin-binding phosphoprotein 50 kDa (also called Na+/H+ exchanger regulatory
factor; Mohler et al., 1999
). These protein complexes may
regulate apical signal transduction pathways leading to changes in ion
transport, cytoskeletal organization, or gene expression in epithelial
cells. Nusrat et al. (2000)
demonstrated that c-Yes kinase
interacts with a 27 amino-acid peptide of the human occludin sequence
in vitro by using a novel bait peptide method. Although c-Src and c-Yes
share high sequence homology outside of their unique domains, Summy
et al. (2000)
showed recently that the SH3 and SH2 domains
between c-Src and c-Yes are capable of directing specificity in protein
interactions. It is possible that c-Yes interacts with occludin through
these specific unique sequences.
Both the occludin-deficient mice and the mice with null mutation of
c-yes gene do not lead to an overt phenotype related to the
tight junction formation (Luton et al., 1999
; Saitou
et al., 2000
). It is well recognized now that the action of
a protein may appear redundant in a null mutant because other related
proteins compensate its function. For example, the double mutant
fyn
/yes
mice develop a renal disease characterized as diffuse segmental glomerulosclerosis (Stein et al., 1994
). These mice show
high levels of proteinuria and hematuria. This phenotype was absent in
fyn- or yes-deficient mice. Our finding that
c-Yes kinase is involved in regulating tight junction formation and
function by tyrosine phosphorylation of tight junction protein may
contribute to the understanding of a subtype of renal pathology.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Dr. Mira Susa for providing the CGP77675 reagent. We thank Dr. David L. Paul for advice and helpful discussion. We gratefully acknowledge support from grants F-270379 and GM-18974 to D.A.G., DK-34854 to Y.H.C. (pilot grant), and GM-37751 to D.L.P.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
cheny{at}mail.ecu.edu.
DOI: 10.1091/mbc.01-08-0423.
| |
REFERENCES |
|---|
|
|
|---|
1 associates with viral and cellular src kinases.
J. Biol. Chem.
268, 10754-10759
2 in the maintenance and biogenesis of epithelial cell tight junctions.
J. Biol. Chem.
273, 21629-21633This article has been cited by other articles:
![]() |
F. Raimondi, P. Santoro, M. V. Barone, S. Pappacoda, M. L. Barretta, M. Nanayakkara, C. Apicella, L. Capasso, and R. Paludetto Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G906 - G913. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mrsny, G. T. Brown, K. Gerner-Smidt, A. G. Buret, J. B. Meddings, C. Quan, M. Koval, and A. Nusrat A Key Claudin Extracellular Loop Domain is Critical for Epithelial Barrier Integrity Am. J. Pathol., April 1, 2008; 172(4): 905 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, S. H. Ramirez, S. Sato, T. Kiyota, R. L. Cerny, K. Kaibuchi, Y. Persidsky, and T. Ikezu Phosphorylation of Claudin-5 and Occludin by Rho Kinase in Brain Endothelial Cells Am. J. Pathol., February 1, 2008; 172(2): 521 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shultz, M. Shmuel, T. Hyman, and Y. Altschuler -tubulin cofactor D and ARL2 take part in apical junctional complex disassembly and abrogate epithelial structure FASEB J, January 1, 2008; 22(1): 168 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Subramanian, J. S. Marchant, D. Ye, T. Y. Ma, and H. M. Said Tight junction targeting and intracellular trafficking of occludin in polarized epithelial cells Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1717 - C1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Sumanasekera, G. U. Sumanasekera, K. A. Mattingly, S. M. Dougherty, R. S. Keynton, and C. M. Klinge Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity Am J Physiol Cell Physiol, August 1, 2007; 293(2): C566 - C573. [Abstract] [Full Text] [PDF] |
||||
![]() |
|